![Laurence Reid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Laurence E.
Reid is currently Director at The Possible Project, Inc., Director at Metagenomi Therapeutics, Inc. since 2025, and Director at Stratus Therapeutics, Inc. since 2022.
Former roles include President, Chief Executive Officer & Director at Warp Drive Bio, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Decibel Therapeutics, Inc. from 2020 to 2023; Chairman at Broken String Biosciences Ltd.; Independent Director at KalVista Pharmaceuticals, Inc. from 2024 to 2026; VP-Business Development & Strategic Planning at Millennium Pharmaceuticals, Inc. from 1993 to 2003; Chief Business Officer at Ensemble Therapeutics Corp.; General Manager at Millennium UK Ltd; and Chief Business Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc. from 2010 to 2014.
Education includes undergraduate studies at the University of Cambridge and a doctorate from King's College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/08/2025 |
The Possible Project, Inc. | Director/Miembro de la Junta | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Director/Miembro de la Junta | 05/01/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Broken String Biosciences Ltd.
 Broken String Biosciences Ltd. BiotechnologyHealth Technology Develops novel cell and gene therapies | Presidente | 16/06/2026 |
| KALVISTA PHARMA | Director/Miembro de la Junta | 11/06/2026 |
| DECIBEL THERAPEUTICS, INC. | Director Ejecutivo | 22/09/2023 |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Director Ejecutivo | 01/10/2018 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Millennium UK Ltd
 Millennium UK Ltd Miscellaneous Commercial ServicesCommercial Services Consulting services | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
The Possible Project, Inc. | |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Broken String Biosciences Ltd.
Broken String Biosciences Ltd. BiotechnologyHealth Technology Develops novel cell and gene therapies | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
